Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mecp2 stabilizes the glucocorticoid system in active chromatin regions [scRNA-Seq]

ABSTRACT: Methyl-CpG-binding protein 2 (MECP2), a key epigenetic factor regulating gene expression via DNA/chromatin interactions, causes multisystem disorders when dysfunctional. However, its epigenetic regulatory mechanisms at the pan-tissue and multi-omics levels remain poorly understood. Here, we established comprehensive pan-tissue expression profiles in wild-type and Mecp2-knockout mice, revealing a crucial role for MECP2 in maintaining glucocorticoid (GC) signaling homeostasis. Single-cell epigenomic analyses demonstrated widespread increases in chromatin accessibility at GC-induced genes (GIGs) upon Mecp2 deficiency. Through innovative single-cell multi-omics profiling of the nervous system, we further revealed that GIG dysregulation primarily disrupts neural homeostasis via non-neuronal cells. Mechanistically, we identified a dual regulatory mode of MECP2: (1) competitively inhibiting NR3C1 binding to the cis-regulatory elements of GIGs in active chromatin regions, and (2) specifically disrupting NR3C1-NCOA1 coactivator interactions. These findings not only elucidate a novel MECP2-NR3C1-NCOA1 axis in GC system regulation but also suggest potential therapeutic targets for Rett syndrome.

ORGANISM(S): Mus musculus

PROVIDER: GSE299346 | GEO | 2026/07/31

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

MeCP2 stabilizes the glucocorticoid system in active chromatin regions [CUT&Tag]

Project description:Methyl-CpG-binding protein 2 (MeCP2), a key epigenetic factor regulating gene expression via DNA/chromatin interactions, causes Rett syndrome when dysfunctional. However, its regulatory mechanisms at the pan-tissue and multi-omics levels remain poorly understood. Here, we constructed comprehensive pan-tissue transcriptional profiles and chromatin accessibility profiles from wild-type and Mecp2-knockout mice. Integrative analyses revealed that glucocorticoid (GC)-induced genes (GIGs) exhibited global hyperactivation following Mecp2 knockout, highlighting a crucial role for MeCP2 in maintaining GC signaling homeostasis. Through innovative single-cell multi-omics profiling of the nervous system, we found that GIG dysregulation primarily disrupts neural homeostasis via non-neuronal cells. Mechanistically, we uncovered a dual regulatory mode of MeCP2: (1) competitively limiting NR3C1 occupancy at GIG cis-regulatory elements in active chromatin regions, and (2) specifically disrupting NR3C1-NCOA1 coactivator interactions. Importantly, pharmacologically suppressing aberrant GC system activation ameliorated pathological phenotypes and significantly prolonged survival in Mecp2-knockout mice. Our study demonstrates the critical pathological role of hyperactivated GC signaling in the multisystem disturbances of Mecp2-knockout mice and suggests potential therapeutic targets for Rett syndrome.

2026-07-31 | GSE298418 | GEO

MeCP2 stabilizes the glucocorticoid system in active chromatin regions [RNA-seq]

2026-07-31 | GSE295530 | GEO

Mecp2 acts as a key stabilizer of glucocorticoid-induced genes in active chromatin regions [scATAC-Seq]

Project description:Mutations in methyl-CpG-binding protein 2 (MECP2) constitute the primary cause of Rett syndrome (RTT). Although Mecp2 is ubiquitously expressed throughout the body, its functional profiling at the pan-tissue and multi-omics levels remains lacking. Here, we obtained transcriptomic and epigenomic profiles of various tissues from wild-type and RTT mice; revealed global hyperactivation of the glucocorticoid (GC)-induced genes (GIGs) following Mecp2 KO. Further analysis of the nervous system revealed that non-neuronal cells were more susceptible to abnormalities of the GC system, playing a crucial role in the neurological disturbances of RTT mice. Mechanistically, we found that MECP2 binds to the regulatory elements of active GIGs to suppress their hyperactivation; and competitively inhibits the binding between NR3C1 and NCOA1 to maintain GC system homeostasis. Our study dissects the critical functions of Mecp2 at the epigenomic, transcriptomic, and protein levels, providing new insights into the pathomechanisms of RTT.

2026-07-31 | GSE298162 | GEO

Single Cell Multi-Omics Profiling Using ISSAAC-seq

Project description:Joint profiling of chromatin accessibility and gene expression from the same single cell provides critical information about cell types in a tissue and cell states during a dynamic process. These emerging multi-omics techniques help the investigation of cell-type resolved gene regulatory mechanisms. Here, we developed in situ SHERRY after ATAC-seq (ISSAAC-seq), a highly sensitive and flexible single cell multi-omics method to interrogate chromatin accessibility and gene expression from the same single cell. We demonstrated that ISSAAC-seq is sensitive and provides high quality data with orders of magnitude more features than existing methods. Using the joint profiles from thousands of nuclei from the mouse cerebral cortex, we uncovered major and rare cell types together with their cell-type specific regulatory elements and expression profiles. Finally, we revealed distinct dynamics and relationships of transcription and chromatin accessibility during an oligodendrocyte maturation trajectory.

2022-06-15 | E-MTAB-11264 | biostudies-arrayexpress

Sequence Features Accurately Predict Genome-wide MeCP2 Binding in vivo

Project description:MECP2 is critical for proper brain development and expressed at near-histone levels in neurons, but the mechanism of its genomic localization remains poorly understood. Using high-resolution MeCP2 binding data, we show that genetic features alone can predict binding with 88% accuracy. Integrating MeCP2 binding and DNA methylation in a probabilistic graphical model, we demonstrate that previously reported methylation preferences may be due to MeCP2âs affinity to GC-rich chromatin, a result replicated using published data. Furthermore, MeCP2 co-localized with nucleosomes, and Mecp2 deletion led to nucleosome repositioning. Finally, MeCP2 binding downstream of promoters correlated with increased expression in Mecp2 deficient neurons. Study of genetic and epigenetic determinants of MeCP2 binding using MeCP2 ChIP-seq, MNase-seq, Bisulfite-seq and RNA-seq. Please see individual sample record for details on experimental design.

2016-03-24 | E-GEOD-71126 | biostudies-arrayexpress

A cell-intrinsic glucocorticoid biosynthesis and sensing circuit maintains homeostatic Th17 cell state

Project description:T helper 17 (Th17) cells are heterogeneous; homeostatic Th17 (Th17Hom) cells maintain tissue homeostasis and pro-inflammatory Th17 (Th17Inf) cells drive autoimmune inflammation. IL-23 drives Th17Inf, but the signals that maintain Th17Hom remain unclear. Here, we found that differential glucocorticoid (GC) production downstream of CYP11A1, a critical enzyme for steroidogenesis, distinguished Th17Hom cells from Th17Inf cells. Although TCR signaling opened the Cyp11a1 locus, TGFβ1 and IL-6, key cytokines for Th17Hom cell differentiation, maintained and amplified Cyp11a1. Th17Hom cell-derived GC signaled through the glucocorticoid receptor (GR), which was higher in Th17Hom cells compared to Th17Inf cells, thereby forming a circuit that maintained the homeostatic state. Integration of multi-omics data from CYP11A1- and GR-deficient Th17Hom cells revealed a gene network underlying this circuit. TGFβ1, a key node in the network, restored GC sensing to Th17Inf. We thus identify a GC signaling circuit that maintains Th17 homeostasis with implications for treating Th17-mediated autoimmunity.

2026-06-12 | PXD063776 | Pride

Dissecting the enhancer gene regulatory network in early Drosophila spermatogenesis

Project description:Cellular decision-making and tissue homeostasis are governed by transcriptional networks shaped by chromatin accessibility. Using single-nucleus multi-omics, we jointly profiled gene expression and chromatin accessibility in 10,335 cells from the Drosophila testis apical tip. This enabled inference of 138 cell type-specific enhancer regulons (eRegulons) using SCENIC+. We functionally validated key transcription factors (TFs), including ovo and klumpfuss (klu), known from other stem cell systems but not previously linked to spermatogenesis. CRISPR-mediated knockout revealed their essential roles in germline stem cell (GSC) regulation, and we provide evidence that they co-regulate shared targets through overlapping enhancer elements. We further uncovered a critical role for canonical Wnt signaling, with Pangolin/Tcf activating lineage-specific targets in the germline, soma, and niche. The Pan eRegulon links Wnt activity to cell adhesion, intercellular signaling and GSC maintenance. Together, our study defines the enhancer-driven regulatory landscape of early spermatogenesis and reveals conserved, combinatorial mechanisms of niche-dependent stem cell control.

2025-06-23 | GSE277132 | GEO

Sequence Features Accurately Predict Genome-wide MeCP2 Binding in vivo

Project description:MECP2 is critical for proper brain development and expressed at near-histone levels in neurons, but the mechanism of its genomic localization remains poorly understood. Using high-resolution MeCP2 binding data, we show that genetic features alone can predict binding with 88% accuracy. Integrating MeCP2 binding and DNA methylation in a probabilistic graphical model, we demonstrate that previously reported methylation preferences may be due to MeCP2’s affinity to GC-rich chromatin, a result replicated using published data. Furthermore, MeCP2 co-localized with nucleosomes, and Mecp2 deletion led to nucleosome repositioning. Finally, MeCP2 binding downstream of promoters correlated with increased expression in Mecp2 deficient neurons.

2016-03-24 | GSE71126 | GEO

NG2 is a target gene of MLL-AF4 that underlies glucocorticoid resistance in infant MLL-rearranged B-ALL by regulating NR3C1 expression through interaction with FLT3

Project description:B-cell acute lymphoblastic leukemia (B-ALL) is the most common pediatric cancer, with long-term overall survival rates of 80%. However, B-ALL harboring rearrangements of the MLL gene (also known as KTM2A), hereinafter termed MLLr B-ALL, is frequently seen in infants and is associated with poor 5-year survival (<30%), frequent relapses, and refractoriness to glucocorticoids (GC). GC are an essential part of the treatment backbone for B-ALL and GC resistance is a major clinical predictor of poor outcome. Unraveling the mechanisms of GC resistance in MLLr B-ALL is, therefore, crucial to guide therapeutic strategies that deepen response after induction therapy. Neuron-glial antigen-2 (NG2) expression is a hallmark of MLLr B-ALL and is minimally expressed in healthy hematopoietic cells. We recently reported that NG2 expression is associated with poor prognosis and that anti-NG2 immunotherapy strongly reduces/delays relapse in xenograft models of MLLr B-ALL. However, despite its contribution to MLLr B-ALL pathogenesis and its diagnostic utility, the role of NG2 in MLLr-mediated leukemogenesis/chemoresistance remains elusive. We show here that NG2 is an epigenetically regulated direct target gene of the leukemic MLL-AF4 fusion protein. NG2 negatively regulates the expression of the GC receptor NR3C1, conferring GC chemoresistance to MLLr B-ALL cells in vitro and in vivo. Mechanistically, NG2 interacts with FLT3 to render ligand-independent activation of FLT3 signaling (a hallmark of MLLr B-ALL) and downregulation of NR3C1 via AP-1-mediated transrepression. Collectively, our study elucidates the role of NG2 in GC resistance in MLLr B-ALL through a FLT3/AP-1-mediated downregulation of NR3C1, providing novel therapeutic avenues for MLLr B-ALL.

2024-07-12 | PXD041875 | Pride

A cell-intrinsic glucocorticoid biosynthesis and sensing circuit maintains homeostatic Th17 cell state [ATAC-seq]

2026-06-12 | GSE320348 | GEO